The Omicron Variant of the Sars-Cov-2 Virus As the Dominant Agent of a New Risk of Disease amid the COVID-19 Pandemic

被引：0
作者：
G. G. Onishchenko
T. E. Sizikova
V. N. Lebedev
S. V. Borisevich
机构：
[1] Sechenov First Moscow State Medical University (Sechenov University),
[2] Ministry of Health of the Russian Federation,undefined
[3] 48th Central Research Institute,undefined
[4] Ministry of Defense of the Russian Federation,undefined
来源：
Herald of the Russian Academy of Sciences | 2022年 / 92卷
关键词：
COVID-19; SARS-CoV-2 virus; Omicron variant; mutations; epidemiological characteristics of disease; vaccination; medical protective means; preventive and curative efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：381 / 391
页数：10
相关论文
共 30 条
  • [1] Starr T. N.(2020)Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding of ACE2 binding Cell 182 1295-1310.e20
  • [2] Allison J. G.(2021)Genotype and phenotype of COVID-19: Their roles in pathogenesis J Microbiol. Immunol. Infection. 54 159-163
  • [3] Hiltin S. K.(2020)Md. M. Rahman, and H. A. Elshabrawy, “Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks Pathogens 9 186-1149
  • [4] Mousavizadeh L.(2020)Olfactory and gustatory outcomes in COVID-19: A prospective evaluation in nonhospitalized subjects Otolaryngol. Head Neck Surg. 163 1144-1671
  • [5] Ghasemi S.(2020)The neurological manifestations of COVID-19: A review article Neurol. Sci. 41 1667-367
  • [6] Ashour H. M.(2020)Prevalence of asymptomatic SARS-CoV-2 infection: A narrative review Ann. Intern. Med. 173 362-292.e6
  • [7] Elkhatib W. F.(2020)Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein Cell 181 281-1548
  • [8] Paderno A.(2020)The convalescent sera option for containing COVID-19 J. Clin. Invest. 130 1545-868
  • [9] Mattavelli D.(2022)Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement Science 375 864-2854
  • [10] Rampinelli V.(2021)Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation Allergy 76 2840-undefined
123